Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk - Results from the EPIC cohort study

International Journal of Cancer

Volumn 135, Issue 2, 2014, Pages 401-412

  Dik, Vincent K ^a   Bueno De Mesquita, H B ^a,b,c   Van Oijen, Martijn G H ^a   Siersema, Peter D ^a   Uiterwaal, Cuno S P M ^a   Van Gils, Carla H ^a   Van Duijnhoven, Fränzel J B ^b,d   Cauchi, Stéphane ^e,f,g   Yengo, Loic ^e,f,g   Froguel, Philippe ^c,e,f,g   Overvad, Kim ^h   Bech, Bodil H ^h   Tjønneland, Anne ⁱ   Olsen, Anja ⁱ   Boutron Ruault, Marie Christine ^j,k,l   Racine, Antoine ^j,k,l   Fagherazzi, Guy ^j,k,l   Kühn, Tilman ^m   Campa, Daniele ^m   Boeing, Heiner ⁿ   Aleksandrova, Krasimira ⁿ   Trichopoulou, Antonia ^o   Peppa, Eleni ^o   Oikonomou, Eleni ^p   Palli, Domenico ^q   Grioni, Sara ^r   Vineis, Paolo ^c,s   Tumino, Rosaria ^t   Panico, Salvatore ^u   Peeters, Petra H M ^a   Weiderpass, Elisabete ^v,w,x,y   Engeset, Dagrun ^v   Braaten, Tonje ^v   Dorronsoro, Miren ^z,aa   Chirlaque, María Dolores ^z,ab   Sánchez, María José ^z,ac,ad   Barricarte, Aurelio ^z,ae   Zamora Ros, Raul ^af   Argüelles, Marcial ^ag   Jirström, Karin ^ah   Wallström, Peter ^ah   Nilsson, Lena M ^ai   Ljuslinder, Ingrid ^ai   Travis, Ruth C ^aj   Khaw, Kay Tee ^ak   Wareham, Nick ^al   Freisling, Heinz ^am   Licaj, Idlir ^am   Jenab, Mazda ^am   Gunter, Marc J ^c   Murphy, Neil ^c   Romaguera Bosch, Dora ^c,an   Riboli, Elio ^c   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e INSTITUT PASTEUR DE LILLE   (France)

^f UNIV LILLE   (France)

^g EGID FR3508 European Genomics Institute of Diabetes   (France)

^h AARHUS UNIVERSITY   (Denmark)

ⁱ DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^j CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^k UNIVERSITÉ PARIS SACLAY   (France)

^l INSTITUT GUSTAVE ROUSSY   (France)

^m GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁿ GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^o HELLENIC HEALTH FOUNDATION   (Greece)

^p UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^q ISPO Cancer Prevention and Research Institute   (Italy)

^r NATIONAL CANCER INSTITUTE   (Italy)

^s HuGeF Foundation   (Italy)

^t CIVILE M P AREZZO HOSPITAL   (Italy)

^u UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^v UNIVERSITY OF TROMSØ   (Norway)

^w Department of Community Medicine Faculty of Health Sciences UiT the Arctic University of Norway ^*  (Norway)

^x KAROLINSKA INSTITUTE   (Sweden)

^y FOLKHÄLSAN RESEARCH CENTER   (Finland)

^z CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^aa BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ab DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ac ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ad Granada Health Research Institute ibs GRANADA   (Spain)

^ae INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^af CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ag PUBLIC HEALTH DIRECTORATE   (Spain)

^ah LUND UNIVERSITY   (Sweden)

^ai UMEÅ UNIVERSITY   (Sweden)

^aj UNIVERSITY OF OXFORD   (United Kingdom)

^ak UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^al UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^am INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^an Instituto de Salud Carlos III   (Spain)

more..

Author keywords

coffee; Colorectal cancer; CYP1A2; NAT2; tea

Indexed keywords

CYTOCHROME P450 1A2;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COFFEE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CYP1A2 GENE; DNA MODIFICATION; FEMALE; FLUID INTAKE; FOLLOW UP; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAT2 GENE; ONCOGENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TEA;

COFFEE; COLORECTAL CANCER; CYP1A2; NAT2; TEA;

ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CAFFEINE; CASE-CONTROL STUDIES; COFFEE; COHORT STUDIES; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP1A2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; TEA;

EID: 84900036010     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28655     Document Type: Article

References (44)

1. Berra B, Colombo I, Sottocornola E, et al. Dietary sphingolipids in colorectal cancer prevention. Eur J Cancer Prev 2002; 11: 193-7.
2. Cavin C, Holzhaeuser D, Scharf G, et al. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002; 40: 1155-63.
3. Glei M, Kirmse A, Habermann N, et al. Bread enriched with green coffee extract has chemoprotective and antigenotoxic activities in human cells. Nutr Cancer 2006; 56: 182-92.
4. Jin H, Tan X, Liu X, et al. The study of effect of tea polyphenols on microsatellite instability colorectal cancer and its molecular mechanism. Int J Colorectal Dis 2010; 25: 1407-15.
5. Higdon JV, Frei B,. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003; 43: 89-143.
6. Higdon JV, Frei B,. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006; 46: 101-23.
7. Brown SR, Cann PA, Read NW,. Effect of coffee on distal colon function. Gut 1990; 31: 450-3.
8. Carter O, Dashwood RH, Wang R, et al. Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts. Nutr Cancer 2007; 58: 60-5.
9. Merighi S, Benini A, Mirandola P, et al. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 2007; 72: 395-406.
10. Li G, Ma D, Zhang Y, et al. Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr 2013; 16: 346-57.
11. Sinha R, Cross AJ, Daniel CR, et al. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 2012; 96: 374-81.
12. Zhang X, Albanes D, Beeson WL, et al. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst 2010; 102: 771-83.
13. Sun CL, Yuan JM, Koh WP, et al. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006; 27: 1301-9.
14. Butler MA, Lang NP, Young JF, et al. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 1992; 2: 116-27.
15. Gu L, Gonzalez FJ, Kalow W, et al. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 1992; 2: 73-7.
16. Gunes A, Dahl ML,. Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics 2008; 9: 625-37.
17. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000; 9: 29-42.
18. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC: AIRC, 2007.
19. Riboli E, Kaaks R,. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26 (Suppl 1): S6-S14.
20. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
21. Margetts BM, Pietinen P,. European Prospective Investigation into Cancer and Nutrition: validity studies on dietary assessment methods. Int J Epidemiol 1997; 26 (Suppl 1): S1-S5.
22. Percy C, Muir CS, Van Holten V,. International classification of diseases for oncology (ICD-O), 2nd edn. Geneva, Switzerland: World Health Organization, 1991.
23. Voight BF, Kang HM, Ding J, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 2012; 8: e1002793.
24. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Center for Human Genetic Research, Massachusetts General Hospital, Harvard, MIT. Am J Hum Genet 2007; 81: 559-75.
25. Purcell S,. PLINK 1.07 package. Available at: http://pngu.mgh.harvard. edu/purcell/plink. Last accessed December 2012.
26. Consensus Human Arylamine N-Acetyltransferase Gene Nomenclature. University of Louisville, School of Medicine, Department of Pharmacology and Toxicology. July 2011. Available from: http://louisville.edu/medschool/ pharmacology/consensus-human-arylamine-n-acetyltransferase-gene-nomenclature. Last accessed October 2013.
27. Bidel S, Hu G, Jousilahti P, et al. Coffee consumption and risk of colorectal cancer. Eur J Clin Nutr 2010; 64: 917-923.
28. Dominianni C, Huang WY, Berndt S, et al. Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial. Br J Cancer 2013; 109: 1352-9.
29. Michels KB, Willett WC, Fuchs CS, et al. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst 2005; 97: 282-92.
30. Naganuma T, Kuriyama S, Akhter M, et al. Coffee consumption and the risk of colorectal cancer: a prospective cohort study in Japan. Int J Cancer 2007; 120: 1542-7.
31. Peterson S, Yuan JM, Koh WP, et al. Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study. Nutr Cancer 2010; 62: 21-9.
32. Simons CC, Leurs LJ, Weijenberg MP, et al. Fluid intake and colorectal cancer risk in the Netherlands Cohort Study. Nutr Cancer 2010; 62: 307-21.
33. Okamura S, Suzuki K, Yanase M, et al. The effects of coffee on conjugation reactions in human colon carcinoma cells. Biol Pharm Bull 2005; 28: 271-4.
34. Cardenas C, Quesada AR, Medina MA,. Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS One 2011; 6: e23407.
35. Post SM, de Wit EC, Princen HM,. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler Thromb Vasc Biol 1997; 17: 3064-70.
36. Huber WW, McDaniel LP, Kaderlik KR, et al. Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat Res 1997; 376: 115-22.
37. Huber WW, Teitel CH, Coles BF, et al. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities. Environ Mol Mutagen 2004; 44: 265-76.
38. Huber WW, Parzefall W,. Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk. Methods Enzymol 2005; 401: 307-41.
39. Huber WW, Rossmanith W, Grusch M, et al. Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem Toxicol 2008; 46: 1230-1238.
40. Hein DW, Doll MA,. Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Pharmacogenomics 2012; 13: 31-41.
41. Djordjevic N, Ghotbi R, Bertilsson L, et al. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. Eur J Clin Pharmacol 2008; 64: 381-5.
42. Djordjevic N, Ghotbi R, Jankovic S, et al. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2-163C>A polymorphism. Eur J Clin Pharmacol 2010; 66: 697-703.
43. Xu M, Bailey AC, Hernaez JF, et al. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 1996; 17: 1429-34.
44. Yang GY, Liao J, Kim K, et al. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998; 19: 611-16.